SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
University of Copenhagen · Copenhagen University Hospital · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,195
total citations
- FWCI
- 22.44
- Percentile
- 100%
- References
- 79
Citations per year
Authors
36- TMThomas Mandel ClausenCorresponding
University of Copenhagen, Copenhagen University Hospital, University of California San Diego
- DRDaniel R. Sandoval
University of California San Diego
- CBCharlotte B. Spliid
University of Copenhagen, Copenhagen University Hospital, University of California San Diego
- JPJessica Pihl
University of Copenhagen, Copenhagen University Hospital, University of California San Diego
- HRHailee R. Perrett
Scripps Research Institute
Topics & keywords
Topics
Keywords
- Biology
- Heparan sulfate
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Virology
- Coronavirus disease 2019 (COVID-19)
- 2019-20 coronavirus outbreak
- Cell biology
- Biochemistry
No related works found for this paper.
Funding
- NSNational Science FoundationAward: 2031989
- UDU.S. Department of DefenseAwards: W81XWH-20-1-0270, W81XWH
- BABill and Melinda Gates FoundationAward: OPP1170236
- UOUniversity of Pennsylvania
- PSPennsylvania State University
- IInnovationsfonden
- MCMassachusetts Consortium on Pathogen Readiness
- NRNational Research Foundation
- DGDanmarks GrundforskningsfondAward: DNRF107
- NINational Institutes of HealthAwards: HL131474, AI007245, R01 AI146779, COVID-19, Project 3, W81XWH, AI135972, AI146779, GM007753, U19 AI135972
- UOUniversity of California, San DiegoAward: HL131474
- HIHuck Institutes of the Life Sciences
- NHNational Heart, Lung, and Blood Institute